Atara Biotherapeutics
-
Bayer signs deal with Atara Biotherapeutics
With the agreement, the German drugmaker will get access to Atara’s CAR T-cell therapy for solid tumours, ATA3271 Germany’s Bayer…
Read More »
With the agreement, the German drugmaker will get access to Atara’s CAR T-cell therapy for solid tumours, ATA3271 Germany’s Bayer…
Read More »